sumatriptan has been researched along with tegaserod in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Chan, KY; Danser, AH; de Vries, R; Leijten, FP; MaassenVanDenBrink, A; Pfannkuche, HJ; van den Bogaerdt, AJ | 1 |
Bönisch, H; Haenisch, B | 1 |
1 review(s) available for sumatriptan and tegaserod
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
5 other study(ies) available for sumatriptan and tegaserod
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Functional characterization of contractions to tegaserod in human isolated proximal and distal coronary arteries.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adolescent; Adult; Benzamides; Coronary Vessels; Female; Humans; In Vitro Techniques; Indoles; Male; Middle Aged; Muscle Contraction; Pyridines; Receptors, Serotonin, 5-HT4; RNA, Messenger; Serotonin 5-HT4 Receptor Agonists; Serotonin Receptor Agonists; Sumatriptan; Vasoconstrictor Agents; Young Adult | 2009 |
Pharmacological characterization of tegaserod at the wild type and 124Cys variant of the human 5-HT1B receptor.
Topics: Adenylyl Cyclases; Animals; Cell Line, Tumor; Colforsin; Coronary Vessels; Cyclic AMP; Genetic Variation; Genotype; GTP-Binding Proteins; Humans; Indoles; Rats; Receptor, Serotonin, 5-HT1B; Serotonin 5-HT1 Receptor Agonists; Sumatriptan; Transfection | 2011 |